Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
Organizer:

HIV, viral hepatitis and TB are cross-border health threats of Europe that disproportionately affect vulnerable populations. Migrants, homeless and prisoners, among others, are at increased risk for multiple infections while also at risk for being lost within the continuum of care. There is a need to focus on improved testing activities and linkage-to-care pathways for these populations as well as an integration of services for populations at risk for multiple infections. This session will cover four cross-border EU programmes focused on improving testing and the cascade of care for vulnerable populations with multiple co-infections. The session objectives are: • Integrated testing approaches that reach vulnerable populations at risk for infection with HIV, viral hepatitis, TB and STIs and lessons learned from the EU initiatives to research the barriers and facilitators. • Models of care that have been successfully developed that result in integrated testing, evaluation, treatment and cures in identified vulnerable populations.

18:30
WESA1101
Welcome introduction and policy framework
Jack Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
Lella Cosmaro, Fondazione Lila Milano Onlus, Italy
18:31
WESA1102
Welcome and introduction to the INTEGRATE Joint Action
Jack Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
Lella Cosmaro, Fondazione Lila Milano Onlus, Italy
18:34
WESA1103
EU Policy framework, presenting the Staff Working Document 2018
Jean Luc Sion, European Commission,, Luxembourg
Slides
18:41
WESA1104
Monitoring the continuum of care and testing in Europe
Andrew Amato, European Centre for Disease Prevention and Control, Sweden
Slides
18:48
WESA1105
Bridging to Eastern Europe and Central Asian countries – opportunities and challenges
Elena Vovc, WHO Regional Office for Europe, Denmark
Slides
18:56
WESA1106
Session 1: Integrated testing approaches – lessons learned and transferability across diseases and borders
Jack Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
Lella Cosmaro, Fondazione Lila Milano Onlus, Italy
18:56
WESA1107
1.1. HepCare: Lessons learned on HCV testing and treatment among key risk groups, including drug users and homeless, through outreach to the community and integration of primary and secondary care services
Jack Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
Slides
19:06
WESA1108
1.2 E-DETECT TB: Find and treat models in Netherlands and UK, transferability to Eastern Europe (Romania and Bulgaria) and options for integrated care delivery
Gerard de Vries, KNCV Tuberculosis Foundation, Netherlands
Slides
19:16
WESA1109
1.3 Questions from the audience and discussion
19:32
WESA1110
Session 2: Round table discussion: Risk groups and co-infections: prevention, linkage to care, and shared care models for care
Jürgen Rockstroh, University of Bonn, Germany
Daniel Simões, HIV in Europe, Portugal
19:31
WESA1111
2.1 Short introductory remarks by INTEGRATE partners
Dorthe Raben, CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, Denmark
Ann Sullivan, Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom
Jordi Casabona, CEISCATT, Spain
Valerie Delpech, Public Health England (PHE), United Kingdom
19:48
WESA1112
2.2 Moderated discussion with panel and audience
Jack Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
Lella Cosmaro, Fondazione Lila Milano Onlus, Italy
Jean Luc Sion, European Commission,, Luxembourg
Andrew Amato, European Centre for Disease Prevention and Control, Sweden
Elena Vovc, WHO Regional Office for Europe, Denmark
Gerard de Vries, KNCV Tuberculosis Foundation, Netherlands
Dorthe Raben, CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, Denmark
Ann Sullivan, Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom
Jordi Casabona, CEISCATT, Spain
Valerie Delpech, Public Health England (PHE), United Kingdom
20:23
WESA1113
Conclusions and next steps
Jack Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
Lella Cosmaro, Fondazione Lila Milano Onlus, Italy